IS6403A - Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun - Google Patents

Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun

Info

Publication number
IS6403A
IS6403A IS6403A IS6403A IS6403A IS 6403 A IS6403 A IS 6403A IS 6403 A IS6403 A IS 6403A IS 6403 A IS6403 A IS 6403A IS 6403 A IS6403 A IS 6403A
Authority
IS
Iceland
Prior art keywords
production
heteroaryl derivatives
new heteroaryl
new
derivatives
Prior art date
Application number
IS6403A
Other languages
English (en)
Inventor
Ruhland Thomas
Krog-Jensen Christian
Mikkelsen Ivan
Rottländer Mario
Mikkelsen Gitte
Knud Moltzen Ejner
Andersen Kim
Original Assignee
H. Lundbeck A/S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S. filed Critical H. Lundbeck A/S.
Publication of IS6403A publication Critical patent/IS6403A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IS6403A 1999-12-30 2002-05-31 Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun IS6403A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901884 1999-12-30
PCT/DK2000/000741 WO2001049683A1 (en) 1999-12-30 2000-12-29 Novel heteroaryl derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
IS6403A true IS6403A (is) 2002-05-31

Family

ID=8108797

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6403A IS6403A (is) 1999-12-30 2002-05-31 Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun

Country Status (22)

Country Link
US (1) US20030050306A1 (is)
EP (1) EP1246820A1 (is)
JP (1) JP2003519229A (is)
KR (1) KR20020063286A (is)
CN (1) CN1414963A (is)
AR (1) AR027133A1 (is)
AU (1) AU2352001A (is)
BG (1) BG106846A (is)
BR (1) BR0016954A (is)
CA (1) CA2395984A1 (is)
CZ (1) CZ20022280A3 (is)
EA (1) EA200200733A1 (is)
HU (1) HUP0204084A3 (is)
IL (1) IL149993A0 (is)
IS (1) IS6403A (is)
NO (1) NO20023188L (is)
NZ (1) NZ519478A (is)
PL (1) PL355610A1 (is)
SK (1) SK9432002A3 (is)
TR (1) TR200201679T2 (is)
WO (1) WO2001049683A1 (is)
ZA (1) ZA200204464B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
AR055203A1 (es) * 2005-08-31 2007-08-08 Otsuka Pharma Co Ltd Derivados de benzotiofeno con propiedades antipsicoticas
JP5349306B2 (ja) 2006-08-21 2013-11-20 ジェネンテック, インコーポレイテッド アザベンゾチオフェニル化合物および使用方法
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion

Also Published As

Publication number Publication date
JP2003519229A (ja) 2003-06-17
AU2352001A (en) 2001-07-16
US20030050306A1 (en) 2003-03-13
BG106846A (en) 2003-02-28
EA200200733A1 (ru) 2002-12-26
SK9432002A3 (en) 2002-11-06
IL149993A0 (en) 2002-12-01
NO20023188D0 (no) 2002-07-01
AR027133A1 (es) 2003-03-12
PL355610A1 (en) 2004-05-04
KR20020063286A (ko) 2002-08-01
NO20023188L (no) 2002-07-01
CN1414963A (zh) 2003-04-30
TR200201679T2 (tr) 2002-10-21
HUP0204084A2 (hu) 2003-03-28
CA2395984A1 (en) 2001-07-12
EP1246820A1 (en) 2002-10-09
ZA200204464B (en) 2003-09-04
HUP0204084A3 (en) 2005-02-28
NZ519478A (en) 2004-02-27
WO2001049683A1 (en) 2001-07-12
CZ20022280A3 (cs) 2002-10-16
BR0016954A (pt) 2003-04-29

Similar Documents

Publication Publication Date Title
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
IS5875A (is) Ásetnar fenýlafleiður, framleiðsla þeirra og notkun
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
IS2040B (is) Pýrasólínafleiður, framleiðsla þeirra og notkun sem lyfja
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20024281D0 (no) Indolderivater, fremgangsmåte for fremstilling av de samme og anvendelse derav
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
DK1163244T3 (da) Thienopyrimidinforbindelser, fremstilling og anvendelse heraf
NO20030301D0 (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
IS2174B (is) Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun
IS7829A (is) Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkun
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1202996T3 (da) Titanforbindelser, fremstilling og anvendelse heraf
ATE505459T1 (de) Dibenzoäb,füazepin-derivate und ihre herstellung
IS6403A (is) Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
IS5940A (is) Bensófúran afleiður, framleiðsla þeirra og notkun
NO20001782L (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20020404D0 (no) Streptograminderivater, deres produksjon og forbindelser derav
NO20022482L (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
DK1246816T3 (da) Substituerede phenylpiperazinderivater, deres fremstilling og anvendelse